Brief: RESVERLOGIX TO RAISE UP TO $10 MILLION
09/06/2017 14:50
June 9 (Reuters) - Resverlogix Corp RVX.TO :
* RESVERLOGIX TO RAISE UP TO $10 MILLION
* RESVERLOGIX - NET PROCEEDS WILL BE USED TO FUND RESEARCH,
DEVELOPMENT ACTIVITIES TRIAL ACTIVITIES RELATED TO PHASE 3
BETONMACE TRIAL, PHASE 2A KIDNEY DIALYSIS TRIAL, FABRY DISEASE
TRIAL
Source text for Eikon: ID:nCNWkpHFLa
Further company coverage: RVX.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Resverlogix
See all newsBrief: Resverlogix Confirms Focus On Treatment Of Post Covid-19 Conditions
Brief: Resverlogix Announces New Research Findings Highlighting Safety Of BD2-Selective BET Inhibitors
Brief: Resverlogix Announces Type C Meeting With FDA For Coral, A Phase 3 High-Risk Covid-19 Outpatient Study
Brief: Resverlogix Expands Phase 2B Clinical Trial For Covid-19 Treatment With First Site In Brazil And Second In Canada
Brief: Resverlogix Announces Commencement Of Patient Enrollment And Dosing In A Phase 2B Trial For COVID-19 Treatment